• Explore /
  • Poster
  • / Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog (LHRHa) during chemotherapy (CT) as a strategy to reduce ovarian failure in early breast cancer (BC) patients.

Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog (LHRHa) during chemotherapy (CT) as a strategy to reduce ovarian failure in early breast cancer (BC) patients.

Abstract Poster

Authors

Matteo Lambertini

Matteo Lambertini

Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Genova, Italy

Matteo Lambertini , Luca Boni , Andrea Michelotti , Teresa Gamucci , Nina Olmeo , Stefania Gori , Monica Giordano , Ornella Garrone , Alessia Levaggi , Francesca Poggio , Sara Giraudi , Claudia Bighin , Paolo Pronzato , Lucia Del Mastro

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Breast Cancer Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Local/Regional Therapy, Survivorship, and Health Policy

Track

Local/Regional Therapy,Survivorship and Health Policy

Sub Track

Survivorship

Clinical Trial Registration Number

NCT00311636

Citation

J Clin Oncol 32, 2014 (suppl 26; abstr 105)

DOI

10.1200/jco.2014.32.26_suppl.105

Abstract #

105

Poster Bd #

A7

Abstract Disclosures

Similar Posters

First Author: Matteo Lambertini

First Author: Michael Untch

First Author: Wolfgang Janni

First Author: Fatima Cardoso